BENTSUR RON

Average Profitability
31.35%
Insider Buys Quantity
57
Insider Buys Sum
$3.56M
Insider Sells Quantity
26
Insider Sells Sum
$1.51M

Insider Activity of BENTSUR RON

According to the SEC Form 4 filings, BENTSUR RON, being in a position of

  1. Chairman & CEO at Nuvectis Pharma, Inc.,
    оver the last 12 months, has bought 28940 shares for $175,726, and sold 0 shares,
    over all time since 2022-02-04, has bought 605675 shares for $3.52M, and sold 0 shares.

The largest purchase of all time was on 2022-02-04 and amounted to 425000 shares of Nuvectis Pharma, Inc. for $2.1M.

The largest sale of all time was on 2021-11-24 and amounted to 37464 shares of Beyond Air, Inc. for $507,071.

Biography of BENTSUR RON

No biography is available at this moment.

2024-11-15PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
20,000
0.0887%
$4.92$98,400-0.81%
2024-05-14PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,940
0.0105%
$6.74$13,076-3.4%
2024-05-10PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
2,000
0.0109%
$6.40$12,800+2.03%
2024-03-18PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
5,000
0.0283%
$10.29$51,450-36.51%
2023-10-10PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
640
0.0038%
$11.08$7,091-31.9%
2023-10-09PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
830
0.0049%
$11.19$9,288-32.61%
2023-10-06PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
250
0.0014%
$11.27$2,818-34.47%
2023-10-05PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,400
0.0076%
$11.09$15,526-31.83%
2023-10-04PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,820
0.0098%
$10.95$19,929-32.59%
2023-08-16PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
115
0.0008%
$15.15$1,742-42.41%
2023-08-15PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
235
0.0015%
$14.34$3,370-41.99%
2023-08-11PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
180
0.0011%
$14.66$2,639-46.24%
2023-08-08PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
120
0.0008%
$14.83$1,780-44.32%
2023-07-21PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
225
0.0015%
$14.85$3,341-44.27%
2023-07-20PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
110
0.0008%
$15.06$1,657-41.35%
2023-07-19PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
200
0.0013%
$14.33$2,866-42.17%
2023-07-14PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
150
0.001%
$15.03$2,255-43.9%
2023-07-07PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
110
0.0008%
$16.19$1,781-44.62%
2023-07-06PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
320
0.0021%
$14.88$4,762-44.4%
2023-06-26PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
750
0.0051%
$16.50$12,375-48.51%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.